Company Search:
Advanced Search
Sponsored Links
Biocorp Sa Company Snapshot
Biocorp Sa operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biocorp Sa with three other companies in this sector in France: Onxeo SA (2018 sales of 6.13 million Euro [US$6.76 million] of which 91% was Operating segment -Rest of the world), Nicox SA (4.03 million Euro [US$4.44 million] ), and Pharnext SA (2.69 million Euro [US$2.97 million] of which 100% was The conduct of research and development ).

Sales Analysis. Biocorp Sa reported sales of 3.89 million Euro (US$4.29 million) for the year ending December of 2018. This represents an increase of 67.6% versus 2017, when the company's sales were 2.32 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biocorp Sa
  Stock Performance Chart for Biocorp Sa
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 13.40
(Figures in Euro)
1 Week 2.3%   13 Weeks 21.8%  
4 Weeks 16.5%   52 Weeks 52.3%  
Biocorp Sa Key Data:
  Ticker: ALCOR Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 3,890,416
(Year Ending Jan 2019).
Employees: 45
  Currency: Euro Market Cap: 53,728,774
  Fiscal Yr Ends: December Shares Outstanding: 4,009,610
  Share Type: Actions Ordinaires Closely Held Shares: 2,000,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.